Search and Filter
Results per Page:
Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients
More than 6% of Americans are immunocompromised, yet most clinical trials exclude them
Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response
A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments
Fred Hutch Cancer Center clinic to be named in honor of Stuart and Molly Sloan for generous gift totaling $100 million
Stuart and Molly Sloan add to their 2022 transformational gift to boost their impact on research and care
Fred Hutch leads new Vanguard Study for Cancer Screening Research Network
Study aims to understand the effectiveness and use of multi-cancer detection blood tests
Fred Hutch names Board of Directors' leadership, adds new board member
Current board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors
Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award
National award honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Fred Hutch announces 10 recipients of the 2025 Harold M. Weintraub Graduate Student Award
Award honors graduate students in biological sciences from across the world
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer